Works matching IS 14642662 AND DT 2006 AND VI 7 AND IP 2

Results: 9

A prospective, 96-week study of the impact of TRIZIVIR, COMBIVIR/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.
Published in:
2006
By:
- Kumar PN;
- Rodriguez-French A;
- Thompson MA;
- Tashima KT;
- Averitt D;
- Wannamaker PG;
- Williams VC;
- Shaefer MS;
- Pakes GE;
- Pappa KA;
- ESS40002 Study Team
Publication type:
Journal Article
Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Published in:
HIV Medicine, 2006, v. 7, n. 2, p. 99, doi. 10.1111/j.1468-1293.2006.00347.x
By:
- Kilaru, K. R.;
- Kumar, A.;
- Sippy, N.;
- Carter, A. O.;
- Roach, T. C.
Publication type:
Article
nef gene sequence variation among HIV-1-infected African children.
Published in:
HIV Medicine, 2006, v. 7, n. 2, p. 75, doi. 10.1111/j.1468-1293.2006.00341.x
By:
- Chakraborty, R.;
- Reinis, M.;
- Rostron, T.;
- Philpott, S.;
- Dong, T.;
- D'Agostino, A.;
- Musoke, R.;
- de Silva, E.;
- Stumpf, M.;
- Weiser, B.;
- Burger, H.;
- Rowland-Jones, S. L.
Publication type:
Article
A prospective, 96-week study of the impact of Trizivir<sup>®</sup>, Combivir<sup>®</sup>/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.
Published in:
HIV Medicine, 2006, v. 7, n. 2, p. 85, doi. 10.1111/j.1468-1293.2006.00346.x
By:
- Kumar, P. N.;
- Rodriguez-French, A.;
- Thompson, M. A.;
- Tashima, K. T.;
- Averitt, D.;
- Wannamaker, P. G.;
- Williams, V. C.;
- Shaefer, M. S.;
- Pakes, G. E.;
- Pappa, K. A.
Publication type:
Article
HIV-related neutropaenia exacerbated by efavirenz.
Published in:
HIV Medicine, 2006, v. 7, n. 2, p. 129, doi. 10.1111/j.1468-1293.2006.00348.x
By:
- Healy, B. J.;
- Freedman, A. R.
Publication type:
Article
Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy.
Published in:
HIV Medicine, 2006, v. 7, n. 2, p. 105, doi. 10.1111/j.1468-1293.2006.00349.x
By:
- Winston, A.;
- Amin, J.;
- Mallon, P. W. G.;
- Marriott, D.;
- Carr, A.;
- Cooper, D. A.;
- Emery, S.
Publication type:
Article
Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
Published in:
HIV Medicine, 2006, v. 7, n. 2, p. 112, doi. 10.1111/j.1468-1293.2006.00350.x
By:
- Gibbie, T.;
- Mijch, A.;
- Ellen, S.;
- Hoy, J.;
- Hutchison, C.;
- Wright, E.;
- Chua, P.;
- Judd, F.
Publication type:
Article
Analysis of genotypic and phenotypic clinical cut-off levels for ritonavir-boosted saquinavir.
Published in:
HIV Medicine, 2006, v. 7, n. 2, p. 67, doi. 10.1111/j.1468-1293.2006.00351.x
By:
- Hill, A.;
- Walmsley, S.;
- Clotet, B.;
- Molto, J.
Publication type:
Article
Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
Published in:
HIV Medicine, 2006, v. 7, n. 2, p. 122, doi. 10.1111/j.1468-1293.2006.00356.x
By:
- Motoya, T.;
- Thevanayagam, L. N.;
- Blaschke, T. F.;
- Au, S.;
- Stone, J. A.;
- Jayewardene, A. L.;
- Chi, J.;
- Aweeka, F. T.
Publication type:
Article